Anticoagulant Use During Extracorporeal Membrane Oxygenation Using Heparin and Direct Thrombin Inhibitors in COVID-19 and ARDS Patients.
Saved in:
| Title: | Anticoagulant Use During Extracorporeal Membrane Oxygenation Using Heparin and Direct Thrombin Inhibitors in COVID-19 and ARDS Patients. |
|---|---|
| Authors: | Stammers AH; SpecialtyCare, Brentwood, Tennessee., Tesdahl EA; SpecialtyCare, Brentwood, Tennessee., Barletti S; SpecialtyCare, Brentwood, Tennessee., Mongero L; SpecialtyCare, Brentwood, Tennessee., Patel K; SpecialtyCare, Brentwood, Tennessee., Mosca M; SpecialtyCare, Brentwood, Tennessee., Sestokas A; SpecialtyCare, Brentwood, Tennessee., Firstenberg MS; St. Elizabeth Medical Center, Appleton, Wisconsin; and., Jacobs JP; University of Florida, Gainesville, Florida. |
| Source: | The journal of extra-corporeal technology [J Extra Corpor Technol] 2022 Sep; Vol. 54 (3), pp. 223-234. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: EDP Sciences Country of Publication: France NLM ID: 0267637 Publication Model: Print Cited Medium: Print ISSN: 0022-1058 (Print) Linking ISSN: 00221058 NLM ISO Abbreviation: J Extra Corpor Technol |
| Database: | MEDLINE Ultimate |
| ISSN: | 0022-1058 |
|---|---|
| DOI: | 10.1182/ject-223-234 |
